BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 3439961)

  • 1. [Production of leukocyte- and thrombocyte-poor erythrocyte preparations].
    Kretschmer V; Köppen-Castrop A; Söhngen D; Lammers M; Egbring R; Prinz H
    Beitr Infusionther Klin Ernahr; 1987; 18():151-4. PubMed ID: 3439961
    [No Abstract]   [Full Text] [Related]  

  • 2. [Leukocyte contamination in standard erythrocyte concentrates, prepared with the Biopack-U-bag and Biotrans separator].
    von Eisenhart-Rothe B; Spinger E; Frank A; Kühnl P
    Beitr Infusionsther; 1990; 26():74-5. PubMed ID: 1703905
    [No Abstract]   [Full Text] [Related]  

  • 3. [Evaluation of the leuko-reductive efficacy of single-donor erythropheresis procedures].
    Domingo JM; Rabasa P; Chueca P; Medarde A
    Sangre (Barc); 1999 Jun; 44(3):238-40. PubMed ID: 10481589
    [No Abstract]   [Full Text] [Related]  

  • 4. [Production of leukocyte-reduced, neocyte-rich erythrocyte concentrate].
    Karakassopoulos A; Müller N
    Beitr Infusionsther; 1990; 26():71-3. PubMed ID: 1703904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Reduction of leukocytes and loss of erythrocytes in production of erythrocyte concentrates using the "top and bottom" principle, a comparison between the equipment combinations Biopack-U/Biotrans Separator and Optipac/Optipress].
    Eisenhart-Rothe B; Polzin F; Kühnl P
    Beitr Infusionsther; 1992; 30():108-11. PubMed ID: 1284684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective study on the use of leucocyte-filters in reducing blood transfusion reactions in multi-transfused thalassemic children.
    Tan KK; Lee WS; Liaw LC; Oh A
    Singapore Med J; 1993 Apr; 34(2):109-11. PubMed ID: 8266145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The blood components--advancement in haemotherapy.
    Nathan IV; Han P
    J Singapore Paediatr Soc; 1986; 28(3-4):216-26. PubMed ID: 3599928
    [No Abstract]   [Full Text] [Related]  

  • 8. Effectiveness of the Imugard E leukocyte removal filter for preparation of leukocyte-poor concentrated red cells.
    Takebe M; Tsubokura M; Amaki I
    Vox Sang; 1990; 59(1):19-22. PubMed ID: 2396368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Thrombocyte preparation from whole blood stores. Data on yield and leukocyte contamination].
    Mayer G; Wernet D; Schnaidt M; Sugg U
    Beitr Infusionther Klin Ernahr; 1986; 15():66-74. PubMed ID: 3753415
    [No Abstract]   [Full Text] [Related]  

  • 10. [Efficacy of 2 different leukocyte filters for erythrocyte concentrates].
    Barth A; Passerini M; Oppliger R; Spycher M; Nydegger U
    Schweiz Med Wochenschr; 1993 Jun; 123(22):1160-4. PubMed ID: 8322051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Blood transfusion is never completely without side-effects. Filtrated erythrocyte concentrates should be used].
    Shanwell A
    Lakartidningen; 2000 Apr; 97(15):1782-3, 1786-7. PubMed ID: 10815405
    [No Abstract]   [Full Text] [Related]  

  • 12. Effectiveness of leukocyte removal by Imugard III.
    Kijkornphan S; Moungkote T; Somboonvit P; Noparat K; Chiewsilp P
    J Med Assoc Thai; 1997 Sep; 80 Suppl 1():S9-12. PubMed ID: 9347639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Removal of erythrocytes from bone marrow preparations by the method of centrifugation in the "liquid for lymphocyte isolation"].
    Wiktor-Jedrzejczak W; Ratajczak MZ
    Acta Haematol Pol; 1987; 18(3-4):216-9. PubMed ID: 3330399
    [No Abstract]   [Full Text] [Related]  

  • 14. [Component therapy with cryo-poor plasma (CPP)].
    Roewer J; Dettmann C
    Beitr Infusionsther; 1990; 26():168-73. PubMed ID: 1703822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative studies for optimizing the collection of blood components in a multiple bag system].
    Taborski U; Müller N
    Beitr Infusionsther; 1988; 21():87-90. PubMed ID: 2463021
    [No Abstract]   [Full Text] [Related]  

  • 16. [Lymphocyte contaminations of leukocyte-poor erythrocyte concentrates following power filtration].
    Müller N; May G
    Beitr Infusionsther; 1988; 21():79-83. PubMed ID: 2463019
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluating leucodepletion systems suitable for routine use.
    Rowe G
    Transfus Sci; 2000; 22(1-2):61-2. PubMed ID: 10771384
    [No Abstract]   [Full Text] [Related]  

  • 18. [Preparation and preservation of labile products obtained from whole blood using the leuko-platelet layer].
    Robert F; Bertholey F; Garic Y; Chataing B
    Rev Fr Transfus Hemobiol; 1989 Dec; 32(6):451-65. PubMed ID: 2629758
    [No Abstract]   [Full Text] [Related]  

  • 19. [Avoidance of transfusion reactions by the use of largely leukocyte- and thrombocyte-free erythrocyte extracts].
    Marcard E; Spiess HG
    Bibl Haematol; 1971; 37():194-8. PubMed ID: 5158186
    [No Abstract]   [Full Text] [Related]  

  • 20. Bedside processing.
    Krause KP
    Vox Sang; 2004 Jul; 87 Suppl 2():76-8. PubMed ID: 15209884
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.